Dr. Reddy's Laboratories Ltd.
8-2-337, Road No. 3, Banjara Hills
Hyderabad – 500 034, Telangana, India
CIN: L85195TG1984PLC004507
Tel: + 91 40 4900 2900
Fax: + 91 40 4900 2999
Email: mail@drreddys.com
Web: www.drreddys.com
| Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India
CIN: L85195TG1984PLC004507
Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.com |
October 3,2026
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd (Stock Code: DRREDDY)
Dear Sir/Madam,
Sub: | Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 |
This is to inform that Dr. Reddy’s Laboratories, Inc. (“DRL Inc”), a step-down wholly owned subsidiary of the Company, received final transcript dated September 25, 2026, from Department of the Treasury, Internal Revenue Service, Cincinnati, OH, US (“IRS”) on Oct 2,2026 classifying an amount $32,350.20 as a penalty levied by IRS. The details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III Para A Sub Para 20 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are as hereunder:
Name of the authority | Department of Treasury, Internal Revenue Service, Cincinnati, OH, US |
Nature and details of the action(s) taken, initiated or order(s) passed | Penalty amount of $32,350.20 due to misclassification of Fiscal year reference at the time of tax payment. |
Date of receipt of direction or order, including any ad-interim or interim orders, or any other communication from the authority | Transcript dated Sept 25,2026 was received by DRL Inc. on Oct 2,2026. |
Details of the violation(s)/ contravention(s) committed or alleged to be committed | Penalty due to misclassification of Fiscal year reference at the time of tax payment. |
Impact on financial, operation or other activities of the listed entity, quantifiable in monetary terms to the extent possible | Based on our evaluation, there is no material impact on financials, operations or other activities of the Company. |
This is for your information and record.
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
K Randhir Singh
Company Secretary, Compliance Officer and Head-CSR